4.8 Article

FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver

期刊

CELL METABOLISM
卷 23, 期 2, 页码 335-343

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2015.12.003

关键词

-

资金

  1. American Diabetes Association [7-13-JF-49]
  2. Edward Mallinckrodt Jr. Foundation
  3. National Institutes of Health (NIH) [R01DK106104, T32 GM067795, P30 DC004657]
  4. Fraternal Order of Eagles Diabetes Research Center
  5. University of Iowa Carver College of Medicine
  6. Novo Nordisk Foundation Center for Basic Metabolic Research
  7. Novo Nordisk scholarship
  8. Lundbeck Foundation
  9. Danish Research Council
  10. Novo Nordisk Foundation
  11. NNF Center for Basic Metabolic Research [Gillum Group] Funding Source: researchfish
  12. Novo Nordisk Fonden [NNF15SA0018486, NNF14OC0009525] Funding Source: researchfish

向作者/读者索取更多资源

The liver is an important integrator of nutrient metabolism, yet no liver-derived factors regulating nutrient preference or carbohydrate appetite have been identified. Here we show that the liver regulates carbohydrate intake through production of the hepatokine fibroblast growth factor 21 (FGF21), which markedly suppresses consumption of simple sugars, but not complex carbohydrates, proteins, or lipids. Genetic loss of FGF21 in mice increases sucrose consumption, whereas acute administration or overexpression of FGF21 suppresses the intake of both sugar and non-caloric sweeteners. FGF21 does not affect chorda tympani nerve responses to sweet tastants, instead reducing sweet-seeking behavior and meal size via neurons in the hypothalamus. This liver-to-brain hormonal axis likely represents a negative feedback loop as hepatic FGF21 production is elevated by sucrose ingestion. We conclude that the liver functions to regulate macronutrient-specific intake by producing an endocrine satiety signal that acts centrally to suppress the intake of sweets.''

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据